Contact Sales

Meet the Team

We are the imaging software people.

Gene Saragnese

Prior to joining the Mirada Medical board as Chairman, Gene Saragnese served as the Philips Healthcare CEO of Philips Imaging Systems from April 2009 until May 2015. Before joining Philips, Mr. Saragnese served as GE Healthcare’s Vice President and General Manager of Molecular Imaging and Computed Tomography. Prior to that, he served as Chief Technology Officer for GE Healthcare. In this role, Mr. Saragnese led Global Product Development Engineering and Component Operations around the world, including Corporate Research sites in New York, China, India and Germany. He has also served as General Manager for GE Medical Systems’ Global MRI business and the leader for GE Medical Systems’ Global MRI Engineering organization. Prior to his career in healthcare, Mr. Saragnese held management roles with GE, RCA, Martin Marietta and Lockheed Martin in the aerospace industry. He is a graduate of Rutgers College of Engineering in New Jersey

Hugh Bettesworth

Hugh Bettesworth has worked in the software industry for over fifteen years, the last twelve in the clinical sector. He joined Mirada in 2001, and took over the development of the company’s image fusion product lines in 2003. Following Mirada’s acquisition by first CTI Molecular Imaging and then Siemens Molecular Imaging, Hugh continued to develop the market for these products, focusing on the delivery of specialist molecular imaging workflows into new markets and in particular the PACS market. He led a management buyout in 2008 which re-established Mirada’s independent status and provided the platform for the innovative software developments that have resulted in Mirada’s subsequent growth and leading technical position today.

Prof. Sir Michael Brady

Prof. Sir Michael Brady FRS, FREng, FMedSci is now Professor of Oncological Imaging in the Department of Oncology at the University of Oxford, having retired in 2010 as Professor of Information Engineering. He is co-Director of the Oxford Cancer Imaging Centre. He combines his work in oncology with a range of entrepreneurial activities. He is Deputy Chairman of Oxford Instruments plc. and also a founding director of successful startup companies such as Guidance and, of course, Mirada Medical. He was elected an Honorary Fellow of the IET and Institute of Physics. He was awarded the IEE Faraday Medal in 2000 and also the IEEE Third Millennium Medal for the UK. In 2005 the Royal Institution awarded Professor Sir Michael Brady the Henry Dale Prize for “outstanding work on a biological topic by means of an original multidisciplinary approach”.

David Gudgin

David Gudgin qualified as a management accountant with ICL before spending 3 years at the BBC. In 1999 he joined 3i as an investor in European technology based in London and Amsterdam. In 2002 he moved to Foursome Investments (now Frog Capital) as the lead investor of two funds, an environmental technology fund and a later stage development capital fund. David joined Close Ventures in 2005 and became a partner in Albion Ventures in 2009. David has a BSc in Economics from Warwick University.

Hugh Bettesworth

Chief Executive

Mary Beth Archibald

Executive Vice President for US Service & Operations

Paul Meskell

VP Marketing and Business Development (APAC)

Neil Stevenson

Software Development Manager

Mark Gooding

Chief Scientist

Sarah Bond

VP Product Management

Anna Griffin

Head of Finance, UK HR and Admin

Dave Lach

Vice President of Sales, North America

(858) 774-4222 l Dave.lach@mirada-medical.com

Peter Bannister

VP Clinical Innovation

Greg Janik

Senior Product Specialist